Hostname: page-component-745bb68f8f-v2bm5 Total loading time: 0 Render date: 2025-01-12T10:32:25.032Z Has data issue: false hasContentIssue false
  • English
  • Français

Prediction of Outcome in Depressed Patients by Weekly Monitoring with the Dexamethasone Suppression Test

Published online by Cambridge University Press:  02 January 2018

I. Schweitzer ,
K. P. Maguire ,
A. H. Gee ,
J. W. G. Tiller ,
N. Biddle  and
B. Davies
I. Schweitzer*
Affiliation:
Department of Psychistry, University of Melbourne
K. P. Maguire
Affiliation:
Department of Psychistry, University of Melbourne
A. H. Gee
Affiliation:
Department of Psychiatry, Royal Melbourne Hospital
J. W. G. Tiller
Affiliation:
Department of Psychiatry, University of Melbourne
N. Biddle
Affiliation:
Department of Psychiatry, University of Melbourne
B. Davies
Affiliation:
Department of Psychiatry, University of Melbourne
*
Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital, Victoria 3050, Australia
Get access Rights & Permissions [Opens in a new window]

Abstract

Forty-three depressed patients in hospital were studied with weekly dexamethasone suppression tests (DSTs) and were followed as out-patients for at least three months after discharge. The detection rate of patients with LHPA axis dysfunction increased from 41% with a single DST to 59% with serial DSTs. There was a poor correlation between weekly post-dexamethasone cortisol levels and Hamilton depression rating scores. In patients with evidence of LHPA axis dysfunction, a DST at discharge discriminated effectively between a good and a poor outcome group; persistent non-suppression was strongly linked with a relapse of depression in the first three months after discharge. In general, our results support previous claims that the DST is a state marker for depressive illness.

Type
Papers
Information
The British Journal of Psychiatry , Volume 151 , Issue 6 , December 1987 , pp. 780 - 784
Copyright
Copyright © Royal College of Psychiatrists, 1987 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albala, A. A. & Greden, J. F. (1980) Serial dexamethasone suppression tests in affective disorders. American Journal of Psychiatry, 137, 383.Google ScholarPubMed
Albala, A. A., Greden, J. F., Tarika, J. & Carroll, B. J. (1981) Changes in serial dexamethasone suppression tests among unipolar depressives receiving electroconvulsive treatment. Biological Psychiatry, 16, 551–560.Google ScholarPubMed
American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn). Washington DC: American Psychiatric Association.Google Scholar
Berger, M., Boerr, P., Bronisch, T. & von Zerssen, D. (1982) Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype? Biological Psychiatry, 17, 1217–1242.Google ScholarPubMed
Bowie, P. C. W. & Beaini, A. Y. (1985) Normalisation of the dexamethasone suppression test: a correlate of clinical improvement in primary depressives. British Journal of Psychiatry, 147, 30–35.CrossRefGoogle Scholar
Braddock, L. (1986) The dexamethasone suppression test: fact and artefact. British Journal of Psychiatry, 148, 363–374.CrossRefGoogle ScholarPubMed
Carroll, B. J. (1985) Dexamethasone suppression test: a review of contemporary confusion. Journal of Clinical Psychiatry, 46, 18–24.Google Scholar
Carroll, B. J., Martin, F. I. R. & Davies, B. (1968) Resistence to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness. British Medical Journal, ii, 285–287.CrossRefGoogle Scholar
Carroll, B. J., Martin, F. I. R., Davies, B. & Davies, B. (1970) Clinical associations of II-hydroxy- cortkosteroid suppression and nonsuppression in severe depressive illness. British Medical Journal, i, 789–791.CrossRefGoogle Scholar
Carroll, B. J., Martin, F. I. R., Davies, B., Davies, B., Curtis, G. C. & Mendels, J. (1976a) Neuroendocrine regulation in depression: I. Limbic system-adrenocortical dysfunction. Archives of General Psychiatry, 33, 1039–1044.CrossRefGoogle ScholarPubMed
Carroll, B. J., Martin, F. I. R., Davies, B., Davies, B., Curtis, G. C. & Mendels, J. (1976b) Neuroendocrine regulation in depression: II. Discrimination of depressed from nondepressed patients. Archives of General Psychiatry, 133, 1051–1058.CrossRefGoogle Scholar
Carroll, B. J., Martin, F. I. R., Davies, B., Davies, B., Curtis, G. C., Mendels, J., Feinberg, M., Greden, J. F., Tarika, J., Albala, A. A. et al (1981) A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Archives of General Psychiatry, 38, 15–22.CrossRefGoogle ScholarPubMed
Galen, R. S. & Gambino, S. R. (1975) Beyond Normality: The Predictive Value and Efficiency of Medical Diagnosis. New York: John Wiley & Sons.Google Scholar
Gerken, A., Maier, W. & Holsboer, F. (1985) Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology. Psychoneuroendocrinology, 10, 261–271.CrossRefGoogle ScholarPubMed
Gold, P. W. & Chrousos, G. P. (1985) Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease and adrenal insufficiency. Psychoneuroendocrinology, 10, 401–419.CrossRefGoogle ScholarPubMed
Goldberg, I. K. (1980a) Dexamethasone suppression test as indicator of safe withdrawal of antidepressant therapy. The Lancet, i, 376.CrossRefGoogle Scholar
Goldberg, I. K. (1980b) Dexamethasone suppression test in depression and response to treatment. The Lancet, ii, 92.CrossRefGoogle Scholar
Greden, J. F., Albala, A. A., Haskett, R. F., James, N. M., Goodman, L., Steiner, M. & Carroll, B. J. (1980) Normalisation of dexamethasone suppression test: a laboratory index of recovery from endogenous depression. Biological Psychiatry, 15, 449–458.Google Scholar
Greden, J. F., Albala, A. A., Haskett, R. F., James, N. M., Goodman, L., Steiner, M., Carroll, B. J., Gardner, R., King, D., Grunhaus, L., Carroll, B. J. & Kronfol, Z. (1983) Dexamethasone suppression tests in antidepressant treatment of melancholia: the process of normalisation and test-retest reproducibility. Archives of General Psychiatry, 40, 493–500.CrossRefGoogle ScholarPubMed
Hirschfeld, R. M. A., Koslow, S. H. & Kupfer, D. J. (1983) The clinical utility of the dexamethasone suppression test: summary of a National Institute of Mental Health workshop. Journal of American Medical Association, 250, 2172–2174.CrossRefGoogle ScholarPubMed
Holsboer, F., Liebl, R. & Hofschuster, E. (1982) Repeated dexamethasone suppression test during depressive illness: normalisation of test result compared with clinical improvement. Journal of Affective Disorders, 4, 93–101.CrossRefGoogle ScholarPubMed
Holsboer, F., Liebl, R., Hofschuster, E., Gerken, A., Steiger, A., Benkert, O., Muller, O. A. & Stalla, G. K. (1984) Corticotropin releasing factor-induced pituitary-adrenal response in depression. The Lancet, i, 55.CrossRefGoogle Scholar
Nemeroff, C. B. & Evans, D. L. (1984) Correlation between the dexamethasone suppression test in depressed patients and clinical response. American Journal of Psychiatry, 141, 247–249.Google ScholarPubMed
Potts, J. T. (1983) Disorders of parathyroid glands. In Harrison's Principles of Internal Medicine (eds R. G. Petersdorf, R. D. Adams, E. Braunwald, K. I. Isselbacher, J. B. Martin & J. D. Wilson). New York: McGraw Hill.Google Scholar
Sachar, E. J. (1967) Corticosteroids in depressive illness. II. A longitudinal psychoendocrine study. Archives of General Psychiatry, 17, 554–567.CrossRefGoogle Scholar
Targum, S. D. (1984) Persistent neuroendocrine dysreguiation in major depressive disorder: a marker for early relapse. Biological Psychiatry, 19, 305–318.Google ScholarPubMed
Yerevanian, B. I., Olafsdottir, H., Milanese, E., Russotto, J., Mallan, P., Baciewicz, G. & Sagi, E. (1983) Normalisation of the dexamethasone suppression test at discharge from hospital: its prognostic value. Journal of Affective Disorders, 5, 191–197.CrossRefGoogle ScholarPubMed
Yerevanian, B. I., Olafsdottir, H., Milanese, E., Russotto, J., Mallan, P., Baciewicz, G., Sagi, E., Privitera, M. R., Milanese, E., Sagei, E. A. & Russorro, J. C. (1984) The dexamethasone suppression test during recurrent major depressive episodes. Biological Psychiatry, 19, 407–412.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.